Greystone Associates                                                                                                           The Power of Insight   
Home About Greystone News Events Contact
 Drug Delivery: Inhaled Pain Management Drugs

Buy This Research

$2,850

 ¤ Buy Now

  Resources   Report
 Inhaled Pain Management Drugs: Products, Demand Factors, Pipeline Prospects and Forecasts
 

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to inhalable formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, inhaled pain drug delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

Publication Date: May 2010

Summary of Contents (See Prospectus for Full Contents)

 

Executive Summary

 

The Pain Management Market Opportunity

 

Evolution in Pain Management Guidelines

Regional Factors in Pain Management Practice

Pain Management Demand Drivers

Competitive Landscape

Factors Limiting Growth

 

Inhalation Technology, Platforms and Design Factors

 

Drug Formulations

    Formulation Technologies

    Excipients and Release Profiles

Oral Inhalation Device Design Factors

    Dry Powder Inhalers

    Metered Dose Inhalers

    Nebulizers

    Aerosolized Discrete Liquid dose

Nasal Inhalation

    Nasal Delivery Pharmacokinetics

    Nasal Device Characteristics

Performance Factors

    Bioavailability

    Dose Reproducibility

    Active Compound Stability

 

Inhaled Pain Management Drugs - Analysis and Forecasts

 

Approved Drugs

    AstraZeneca

    GlaxoSmithKline

    Mylan

    Novex

    Roxane

    Valeant

Development-Stage Drugs

    Butorphanols

    Fentanyls

    Dihydroergotamines

    Morphines

    Penthrox

    Perchlorperazine

    Triptans

                                                                                         

Market Factors

 

Usability and Patient Preferences

Regulatory Issues

Patient Compliance

The Role of CMOs/CSOs

 

Company Profiles

 

 

 

 
About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.